INTRODUCTION {#sec1}
============

Redundancy in hexose transporters is a common feature in living cells, which is best exemplified by the multiplicity of transmembrane proteins that are able to transport glucose, with a broad range of rates and affinities, found in *Saccharomyces cerevisiae* (Kruckeberg [@bib17]; Boles and Hollenberg [@bib3]; Özcan and Johnston [@bib28]; Maier *et al.*[@bib21]). This complexity has turned *S. cerevisiae* into an attractive and powerful model to study the mechanisms connecting extracellular signals to transcriptional responses in eukaryotes (Rolland, Winderickx and Thevelein [@bib35]). While its redundancy in hexose transporter genes initially complicated the use of *S. cerevisiae* as a testbed for heterologous transporters, the construction of an *S. cerevisiae* hexose-transport deficient strain (named EBY.VW4000 or *Hxt^0^*) (Wieczorke *et al.*[@bib51]) provided a unique and intensively used platform for functional analysis of native hexose transporters and studies on hexose transport (see for instance Wieczorke *et al.*[@bib50]; Schussler *et al.*[@bib38]; Price *et al.*[@bib30]; Young *et al.*[@bib54]; Xuan *et al.*[@bib52]; Boles and Oreb [@bib4]) and of transport of other biotechnologically relevant sugars (Young, Lee and Alper [@bib53]; Thomik *et al.*[@bib43]).

In EBY.VW4000, which was derived from the CEN.PK strain lineage (Entian and Kötter [@bib9]), complete abolishment of hexose uptake required the deletion of 21 genes: *HXT1* to *HXT16*, *GAL2*, *STL1*, *AGT1* (also known as *MAL11*), *MPH2* and *MPH3* (*HXT17* is absent in the CEN.PK family; Wieczorke *et al.*[@bib51]) in 17 deletion rounds. With the exception of *GAL2*, whose deletion was performed using *URA3* as selectable marker and 5-FOA for marker recycling, all genes were deleted using the marker module KanMX (Wach *et al.*[@bib48]) flanked by LoxP sites. Each deletion was followed by excision of the marker module by the Cre recombinase targeting the LoxP sites (Güldener *et al.*[@bib12]). While the deletion of 21 genes in 17 sequential rounds of selective cultivation resulted in only a small number of single-nucleotide mutations, the repetitive use of the LoxP/Cre system for gene deletion and marker recycling has caused large genome alterations (Solis-Escalante *et al.*[@bib40]). During the strain construction process, four different chromosomal translocations occurred between six distinct LoxP scars, resulting in four neo-chromosomes and two truncated versions of existing chromosomes, IV-t and XV-t. These translocations also resulted in the loss of two subtelomeric regions harboring eight genes. While the physiology of EBY.VW4000 has not been extensively explored, its sporulation and spore-germination deficiencies upon crossing with strains from the parental lineage indicated that drastic chromosomal rearrangements and gene loss influenced its physiology (Solis-Escalante *et al.*[@bib40]).

Since the construction of EBY.VW4000, the advent of CRISPR-based genome editing has revolutionized strain construction. Extensive genetic engineering programs that would cost years of intensive effort in the pre-CRISPR era are now attainable within months (Mans *et al.*[@bib22]). The RNA-guided endonucleases, such as *Streptococcus pyogenes* Cas9 (*Sp*Cas9), can efficiently and precisely edit multiple genomic loci to simultaneously perform gene deletion or integration, or to introduce single nucleotide mutations. While several CRISPR-based approaches have been developed to enable multiplex genome editing (Bao *et al.*[@bib1]; Świat *et al.*[@bib42]; Ferreira *et al.*[@bib10]), so far the record in *S. cerevisiae* is of six simultaneously edited loci with six single guide RNAs using *Sp*Cas9 (Mans *et al.*[@bib22]). Furthermore, while genome editing can be specifically designed to cause chromosomal rearrangements, intensive utilization of *Sp*Cas9 for strain construction has not been reported to induce unwanted and untargeted recombinations between chromosomes. CRISPR/*Sp*Cas9 therefore appears to be a very promising methodology to rapidly and accurately construct novel hexose transport-deficient *S. cerevisiae* strains.

The goal of the present study was to develop a simple and fast CRISPR-based strategy to construct hexose-transport deficient *S. cerevisiae* strains with minimum alterations in genome sequence and structure. To this end, a series of six plasmids carrying combinations of single guide RNAs (sgRNAs) targeting the 21 hexose transporters was constructed. Exploiting the strong homology of hexose transporters, the number of single guide RNAs could be minimized to 11, enabling the complete deletion of all hexose transporters in three transformations rounds only. The genome sequence and copy number variation of the resulting CRISPR-*Hxt^0^* strain IMX1812 were characterized by Illumina sequencing and its chromosomal architecture was explored by a combination of Nanopore sequencing, karyotyping and flow cytometry-based ploidy analysis. Finally, the ability of the CRISPR-*Hxt^0^* strain to grow on various hexoses was investigated.

MATERIALS AND METHODS {#sec2}
=====================

Strains, media and storage {#sec2-1}
--------------------------

The *Saccharomyces cerevisiae* strains used in this work belong to the CEN.PK family (Entian and Kötter [@bib9]; Salazar *et al.*[@bib36]) and are listed in Table [1](#tbl1){ref-type="table"}. The strains were grown at 30°C in 500 mL flasks containing 100 mL chemically defined medium (synthetic medium, SM) (Verduyn *et al.*[@bib47]) or yeast extract peptone (YP) medium supplemented with 20 g L^−1^ glucose (YPD) or 6.8 g L^−1^ maltose (YPM) in an Innova incubator shaker (New Brunswick Scientific, Edison, NJ) set at 200 rpm. SM contains 3 g L^−1^ KH~2~PO~4~, 0.5 g L^−1^ MgSO~4~·7H~2~O, 5 g L^−1^ (NH~4~)~2~SO~4~, 1 ml L^−1^ of trace element solution and 1 ml L^−1^ of vitamin solution as described in (Verduyn *et al.*[@bib47]). YP medium contains 10 g L^−1^ yeast extract and 20 g L^−1^ peptone. When required, SM was supplemented with 150 mg L^−1^ uracil, 125 mg L^−1^ histidine, 500 mg L^−1^ leucine and/or 75 mg L^−1^ tryptophan (Pronk [@bib31]).

###### 

Strains used in this study.

  Name           Relevant genotype                                                                                                                                                                                                                                                                                                         Parental strain   Origin
  -------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------- ------------------------------
  CEN.PK113-7D   *MAT*a *URA3 TRP1 LEU2 HIS3*                                                                                                                                                                                                                                                                                                                (Entian and Kötter [@bib9])
  CEN.PK2-1C     *MAT*a *ura3-52 trp1-1 his3*Δ                                                                                                                                                                                                                                                                                                               (Entian and Kötter [@bib9])
  CEN.PK122      *MATa/MATα*                                                                                                                                                                                                                                                                                                                                 (Entian and Kötter [@bib9])
  EBY.VW4000     *MAT*a *ura3-52 trp1-1 leu2-3,112 his3*Δ *hxt13*Δ*::loxP hxt15*Δ*::loxP hxt16*Δ*::loxP hxt14*Δ*::loxP hxt12*Δ:*:loxP hxt9*Δ*::loxP hxt11*Δ*::loxP hxt10*Δ::*loxP hxt8*Δ*::loxP hxt4-1-5*Δ*::loxP hxt2*Δ*::loxP hxt3-6-7*Δ*::loxP gal2*Δ *stl1*Δ*::loxP agt1*Δ*::loxP mph2*(*ydl247w*)Δ*::loxP mph3*(*yjr160c*)Δ*::loxP*   CEN.PK2-1C        (Wieczorke *et al.*[@bib51])
  IMX672         *MAT*a *ura3-52 trp1-1 leu2-3,112 his3*Δ *can1*Δ*::Spcas9-natNT2*                                                                                                                                                                                                                                                         CEN.PK2-1C        (Mans *et al.*[@bib23])
  IMX1521        *MAT*a *ura3-52 trp1-1 leu2-3,112 his3*Δ *can1*Δ*::Spcas9-natNT2 gal2*Δ *hxt4-1-5*Δ *hxt3-6-7*Δ*::ars4 hxt8*Δ *hxt14*Δ                                                                                                                                                                                                    IMX672            This study
  IMX1541        *MAT*a *ura3-52 trp1-1 leu2-3,112 his3*Δ *can1*Δ*::Spcas9-natNT2 gal2*Δ *hxt4-1-5*Δ *hxt3-6-7*Δ*::ars4 hxt8*Δ *hxt14*Δ *hxt2*Δ *hxt9*Δ *hxt10*Δ *hxt12*Δ *hxt13*Δ *hxt15*Δ *hxt16*Δ                                                                                                                                       IMX1521           This study
  IMX1812        *MAT*a *ura3-52 trp1-1 leu2-3,112 his3*Δ *can1*Δ*::Spcas9-natNT2 gal2*Δ *hxt4-1-5*Δ *hxt3-6-7*Δ*::ars4 hxt8*Δ *hxt14*Δ *hxt2*Δ *hxt9*Δ *hxt10*Δ *hxt11*Δ *hxt12*Δ *hxt13*Δ *hxt15*Δ *hxt16*Δ *mph2*(*ydl247w*)Δ *mph3*(*yjr160c*)Δ *mal11*Δ *stl1*Δ                                                                       IMX1541           This study

To obtain solid media, 2% (w/v) agar was added. Yeast strains and *Escherichia coli* cultures were stored by adding glycerol to the cultures to a final concentration of 30% (v/v) and stored at --80°C.

Molecular biology techniques {#sec2-2}
----------------------------

Plasmids were isolated from *E. coli* with the GenElute Plasmid Miniprep Kit (Sigma Aldrich, St. Louis, MI) according to the supplier\'s instruction. DNA amplification was performed by PCR using Phusion® High-Fidelity DNA polymerase (Thermo Fisher Scientific, Waltham, MA) as previously described (Mans *et al.*[@bib23]). Separation of DNA fragments was done in 1% (w/v) agarose gel (Thermo Fisher Scientific) with SERVA DNA Stain Clear G in 1x TAE buffer (Thermo Fischer Scientific). DNA fragments were isolated from gel using the Zymoclean Gel DNA Recovery Kit (Zymo Research, Irvine, CA). DNA concentrations were measured with a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific). Plasmids were constructed *in vitro* with NEBuilder® HiFi DNA Assembly Master Mix (New England Biolabs, Beverly, MA) according to manufacturer\'s protocol, but with reaction volumes down-scaled by 4-fold. Colony PCR was performed using DreamTaq PCR Master Mix (2x) (Thermo Fisher Scientific). Following the manufacturer\'s instruction. Yeast transformation was performed with the LiAc/ssDNA method (Gietz and Woods [@bib11]). Yeast genomic DNA was extracted as previously described (Lõoke, Kristjuhan and Kristjuhan [@bib20]) prior to colony PCR.

Plasmid construction {#sec2-3}
--------------------

The double sgRNA method for CRISPR/*Sp*Cas9-mediated deletions based on pROS plasmid series (Mans *et al.*[@bib23], [@bib24]) was used to construct several sgRNA plasmids. The guide RNA sequences were selected to perform the 21 hexose transporter deletions in a minimal number of transformation rounds. Based on alignments of *HXT* gene sequences, considering sequences with AT content above 65% and the absence of strong secondary structures, 11 sgRNAs were designed (sgRNA labelled 1 to 11, Fig. [1B](#fig1){ref-type="fig"}) to yield a kit of six sgRNA-carrying plasmids.

![(**A**) Overview of the chromosomal localization of the deleted hexose transporters. Genes indicated with the same color were removed in the same deletion round. Red, first round; blue, second round; green, third round. (**B**) Deletion strategy. The scissors indicate the gene targeted by *Sp*Cas9 editing. The circled numbers indicate the sgRNA used to guide *Sp*Cas9 for editing.](foy107fig1){#fig1}

The sgRNA plasmids were assembled *in vitro* from two DNA parts (using NEBuilder HiFi DNA Assembly Master Mix, New England Biolabs). The first part was the plasmid backbone obtained by PCR with Phusion polymerase, using a single primer (6005, Supplemental Material [1](#sup1){ref-type="supplementary-material"}) binding at each of the two *SNR52* promoters of either pROS10, pROS14 or pROS16 (Table [2](#tbl2){ref-type="table"}; Mans *et al.*[@bib24]). The second part was a 2 μm fragment surrounded by two sgRNA sequences. This fragment was obtained by PCR amplification (DreamTaq polymerase) of the 2 μm of pROS10 using primers containing the specific 20 bp sgRNA recognition (target) sequence and a 50 bp sequence, homologous to the linearized plasmid backbone. Plasmid assembly was followed by chemical transformation to chemically competent *E. coli* XL1-blue cells according to the supplier\'s instructions (Agilent Technologies, Santa Clara, CA) for storage and plasmid propagation, in Lysogeny Broth (LB) medium with 100 mg L^−1^ ampicillin.

###### 

Plasmids used in this study.

  Name      Relevant characteristics                                    Addgene \#   Origin
  --------- ----------------------------------------------------------- ------------ --------------------------------
  pRS416    *CEN6/ARS4* ampR *URA3*                                                  (Sikorski and Hieter [@bib39])
  pROS10    2 μm ampR *URA3* sgRNA-*CAN1*.Y sgRNA-*ADE2*.Y              \#107924     (Mans *et al.*[@bib23])
  pROS14    2 μm ampR *KlLEU2* sgRNA-*CAN1*.Y sgRNA-*ADE2*.Y            \#107928     (Mans *et al.*[@bib23])
  pROS16    2 μm ampR *HIS3* sgRNA-*CAN1*.Y sgRNA-*ADE2*.Y              \#107930     (Mans *et al.*[@bib23])
  pUDR211   2 μm ampR *KlLEU2* sgRNA3-*HXT8* sgRNA4-*HXT14*             \#113870     This study
  pUDR214   2 μm ampR *URA3* sgRNA5- *HXT13-15-16* sgRNA6-*HXT2*        \#113871     This study
  pUDR217   2 μm ampR *HIS3* sgRNA9-*MPH2-3* sgRNA10-*MAL11*            \#113872     This study
  pUDR220   2 μm ampR *KlLEU2* sgRNA8-*HXT10* sgRNA7-*HXT9-11-12*       \#113873     This study
  pUDR295   2 μm ampR *HIS3* sgRNA2-*GAL2* sgRNA1-*HXT4-1-5;HXT3-6-7*   \#113874     This study
  pUDR418   2 μm ampR *URA3* sgRNA11-*STL1* sgRNA11-*STL1*              \#113875     This study

The *E. coli* colonies were picked and mixed directly in the DreamTaq PCR mix, containing primers binding to the specific 20 bp recognition sequence (primers 11662-11670, 11756) together with two primers binding in the plasmid backbone (primers 4034 and 5941), confirming the presence of one or two target sgRNAs. This PCR will result in four products, since the sgRNA primer can bind on either side of the 2 μM fragment. The orientation of the 2 μm fragment was confirmed by restriction with FastDigest enzymes (Thermo Fisher Scientific) following the supplier\'s manual. All primers for plasmid construction, diagnostic PCR and sequencing are listed in Supplemental Material [1](#sup1){ref-type="supplementary-material"}.

The plasmids pUDR211 and pUDR220 were constructed by *in vitro* assembly with the backbone of pROS14 (*KlLEU2*, Addgene plasmid \#107928; Mans *et al.*[@bib24]) and insert fragment amplified with primers containing the *HXT8* (primer 9575) and *HXT14* (9577) recognition sequences and primers containing the *HXT10* (9576) and *HXT9*, *HXT11*, *HXT12* (9572) recognition sequences, respectively. Similarly, the plasmids pUDR214 and pUDR418 were constructed with the pROS10 backbone (*URA3*) (Addgene plasmid \#107924; Mans *et al.*[@bib24]) and insert fragment amplified with primers containing spacer sgRNA targeting *HXT2* (9574) and *HXT13*, *HXT15*, *HXT16* (9573) recognition sequences and insert fragment amplified with primers containing the spacer sgRNA targeting *STL1* (primer 13616) respectively (Fig. [1](#fig1){ref-type="fig"}). The plasmids pUDR217 and pUDR295 were constructed with the pROS16 backbone (*HIS3*, Addgene plasmid \#107930; Mans *et al.*[@bib24]) and insert fragments amplified with primers containing spacers sgRNA targeting *MPH2*, *MPH3* (primer 9579) and *MAL11* (primer 9585) recognition sequences and insert fragments amplified with primers containing spacers sgRNA targeting *GAL2* and *HXT1,3-7* respectively. Plasmid confirmation was performed by Sanger sequencing (using primers 2758, 6197, 8556 and 2918) (BaseClear B.V., Leiden, The Netherlands).

Strain construction {#sec2-4}
-------------------

The CRISPR/*Sp*Cas9 system with double sgRNA-containing plasmids was used to delete 21 genes in the quadruple auxotrophic strain IMX672 in three transformation rounds (Mans *et al.*[@bib23]). As described above, six sgRNA expression plasmids were constructed, pUDR211, pUDR214, pUDR217, pUDR220, pUDR295 and pUDR418 (Table [2](#tbl2){ref-type="table"}). Strains were transformed with combinations of two plasmids together with double-stranded DNA fragments (repair DNA) designed to repair the double strand break created by *Sp*Cas9. With one exception, repair DNA was a 120 bp oligonucleotide sequence composed of two adjacent 60 bp sequences homologous to sequences located up- and downstream of the DNA break. To prepare the repair DNA fragments, two 120 bp complementary single-stranded oligonucleotides (Supplemental Material [1](#sup1){ref-type="supplementary-material"}) were heated for 5 min at 95°C and then cooled to room temperature. To confirm correct annealing, the dsDNA concentration was measured with Qubit fluorometer 2.0 and Qubit dsDNA BR Assay kit (Thermo Fisher Scientific). Deletion of the adjacent *HXT3*, *HXT6* and *HXT7* resulted in the loss of *ARS432*. To prevent potential replication problems, the repair DNA carried *ARS4*, amplified by PCR from pRS416 with primers 9525 and 9526. Transformation of *S. cerevisiae* was performed as previously described (Gietz and Woods [@bib11]).

The first transformation was accomplished with 1 μg of each plasmid pUDR211 and pUDR295 (Table [2](#tbl2){ref-type="table"}), together with 2 μg of each corresponding repair oligonucleotide (Supplemental Material [1](#sup1){ref-type="supplementary-material"}). The gene deletions were confirmed by PCR and plasmids were subsequently removed by growing one positive clone in 100 mL YPM medium at 30°C with aeration until the end of the exponential growth on glucose. This procedure was repeated by inoculating 1 μL of the culture to a new 100 mL YPM flask. At the end of the exponential growth phase, the culture was plated on YPM agar to obtain single colonies. Plasmid loss was confirmed by re-streaking single colonies on plates with selective and non-selective media. A single colony, unable to grow on selective medium, was inoculated in liquid YPM and grown overnight in an incubator at 30°C. The strain was stocked as IMX1521 and used for the second round of transformation, in which 2 μg of each plasmid, pUDR214 and pUDR220, and 2 μg of each corresponding repair oligonucleotide were transformed. The genotype was confirmed by PCR and the plasmids were recycled as described above, resulting in strain IMX1541. This strain was transformed with 2 μg of each plasmid pUDR217 and pUDR418, and with 2 μg of each corresponding repair oligonucleotide. The genotype was confirmed by PCR and the plasmids were removed, resulting in strain IMX1812. For the second and third transformation rounds, liquid and solid cultures were supplied with maltose as carbon source.

CHEF electrophoresis {#sec2-5}
--------------------

For chromosome separation, contour-clamped homogeneous electric field (CHEF) electrophoresis was used. The CHEF Yeast Genomic DNA Plug Kit (Bio-Rad, Richmond, CA) was used to prepare 1% agarose plugs as recommended by the supplier. The agarose plugs were placed in a 1% megabase agarose gel in 0.5x TBE buffer (Thermo Fisher Scientific), together with the Lambda PFG Ladder (New England Biolabs). The CHEF-DRIII Pulsed Field Electrophoresis system (Bio-Rad) chilled to 14°C was used with a voltage of 5 V/cm, a pulse angle of 120° and pulse time of 60 s during 28 h followed by a pulse time of 90 s for another 16 h. The CHEF gel was stained in 200 mL 0.5x TBE with 3 μg mL^−1^ ethidium bromide followed by de-staining in 200 mL 0.5× TBE. Images were taken using a UV transilluminator.

Flow cytometric measurement of DNA content {#sec2-6}
------------------------------------------

A sample of an exponentially growing aerobic shake-flasks culture was washed with demineralized water, fixed in 70% ethanol and stored at 4°C. Approximately 1 × 10^7^ ethanol-fixed cells were washed with 50 mM Tris-HCl buffer at pH 7.5. The pellet was suspended in the same buffer supplemented with 1 mg mL^−1^ RNase A and incubated at 37°C for 2 h. Trypsin was added to a final concentration of 3.3 mg mL^−1^, and the cell suspension was incubated at 37°C for 2 h. Cells were subsequently washed with 50 mM Tris-HCl pH 7.5 buffer, suspended to a final concentration of 2 × 10^7^ cells per mL in 50 mM Tris-HCl pH 7.5 buffer and stored on ice. A total of 2 × 10^6^ cells were mixed in 50 mM Tris-HCl pH 7.5 buffer with or without 1μM Sytox Green Nucleic Acid stain (Sigma), sonicated at 6 μm peak-to-peak amplitude (MSE Soniprep 150, Fisher Scientific, Loughborough, United Kingdom) for 15 s and stored on ice. Analysis was done on a BD-AccuriTM C6 flow cytometer equipped with a 488 nm excitation laser (Becton Dickinson, Franklin lakes, NJ). A minimum of 1000 events were analyzed in FlowJo v10.4.1 (FlowJo LLC, Ashland, OR) to determine the DNA content of the constructed strains. Exponentially growing aerobic shake-flask cultures of the haploid *S. cerevisiae* strain CEN.PK113-7D and the diploid strain CEN.PK122 were used to identify the fluorescence intensity corresponding to 1 and 2 N peaks, respectively.

Whole genome sequencing {#sec2-7}
-----------------------

### Illumina sequencing {#sec2-7-1}

Genomic DNA of IMX1812, IMX672, IMX1541 and CEN.PK2-1C was isolated using the Qiagen 100/G Kit (Qiagen, Hilden, Germany) following the manufacturer\'s recommendations. DNA concentration was quantified using a Qubit® Fluorometer 2.0 with Qubit dsDNA BR Assay kit. The genomic DNA of IMX1812 was used to obtain a 300 cycle paired-end library with insert-size of 550 bp and sequenced in-house on a MiSeq sequencer (Illumina, San Diego, CA) using TruSeq DNA PCR-free library preparation. Sequence data are available at NCBI under Bioproject accession number PRJNA478763.

### MinION sequencing {#sec2-7-2}

For Nanopore sequencing, a 1D sequencing library (SQK-LSK108) was prepared according to the manufacturer\'s recommendation, shearing DNA with g-TUBE (Covaris Ltd, Brighton), and loaded onto an FLO-MIN106 (R9.4) flow cell, connected to a MinION Mk1B unit (Oxford Nanopore Technology, Oxford, UK). MinKNOW software (version 1.11.5; Oxford Nanopore Technology) was used for quality control of active pores and for sequencing. Raw files generated by MinKNOW were base called, on a local compute server (HP ProLiant DL360 G9, 2x XEON E5-2695v3 14 Cores and 256 GB RAM), using Albacore (version 1.2.5; Oxford Nanopore). Reads, in fastq format, with minimum length of 1000 bp were extracted, yielding 7.15 Gigabase of sequence with an average read length of 7.3 kb. Sequencing data are available at NCBI under Bioproject accession number PRJNA478763.

### *De novo* assembly {#sec2-7-3}

*De novo* assembly was performed using Canu (v1.4, settings: genome size = 12 m) (Koren *et al.*[@bib15]) producing a 12.16 Megabase genome. Paired-end Illumina library was aligned, using BWA (Li and Durbin [@bib18]), to the assembly and the resulting BAM file (Binary Alignment Map file) was processed by Pilon (Walker *et al.*[@bib49]) for polishing the assembly (for correcting assembly errors), using correction of only SNPs and short indels (--fix bases parameter). Gene annotations were performed using the MAKER2 annotation pipeline (version 2.31.9) (Holt and Yandell [@bib13]) using SNAP (version 2013--11-29) (Korf [@bib16]) and Augustus (version 3.2.3) (Stanke *et al.*[@bib41]) as *ab initio* gene predictors. S288C EST and protein sequences were obtained from SGD (*Saccharomyces* Genome Database, <http://www.yeastgenome.org/>) and were aligned using BLASTX (BLAST version 2.2.28+) (Camacho *et al.*[@bib6]). Translated protein sequences of the final gene model were aligned using BLASTP to S288C protein Swiss-Prot database. Custom made Perl scripts were used to map systematic names to the annotated gene names.

### Analysis of copy number variation {#sec2-7-4}

Illumina reads from IMX1812 and CEN.PK2-1C were co-assembled to detect copy number variation between the two strains by applying the Magnolya algorithm (Nijkamp *et al.*[@bib27]).

Growth tests on solid media {#sec2-8}
---------------------------

Cells from a frozen stock were inoculated in liquid YPM or SM medium supplemented with maltose, uracil, histidine, leucine and tryptophan and grown aerobically at 30°C, 200 rpm. After 8 h, the optical density at 660 nm was measured with a JENWAY 7200 spectrophotometer (Cole-Parmer, Stone, UK). An appropriate volume of cell suspension was spun down (3000 g, 2 min at 4°C) and washed with sterile water, then transferred to a fresh 500 mL shake flask with an initial OD~660~ of 0.5 and cultivated for 4 hours at 30°C. After measuring OD~660~ in triplicate, cells were collected by centrifugation (3000 g, 2 min at 4°C), washed with sterile water and resuspended to a concentration of 10^7^ cells mL^−1^. From this cell suspension, a 10x serial dilution was prepared in water with final concentration of 10^3^ cells mL^−1^. Then, 10 μL of each concentration were spotted on selective SM agar plates supplemented with uracil, tryptophan, leucine and histidine with 20 g L^−1^ glucose, 6.8 g L^−1^ maltose, 20 g L^−1^ mannose, 20 g L^−1^ galactose, or 20 g L^−1^ fructose as carbon source and grown for 2 days at 30°C.

Growth test in shake flask {#sec2-9}
--------------------------

All liquid cultures with SM were supplemented with uracil, histidine, leucine and tryptophan and grown aerobically in 500 mL shake-flasks at 30°C, 200 rpm. For growth rate determination, cells were inoculated from a frozen stock culture in 100 mL SM medium with 6.8 g L^−1^ maltose as carbon source. After 8 h of incubation, optical density at 660 nm was measured with a JENWAY 7200 spectrophotometer. Cells were transferred to an initial OD~660~ of 0.01 and grown overnight in the same medium. The next morning, exponentially growing cultures were transferred to fresh 100 mL SM maltose medium (initial OD~660~ ∼0.1) and the OD was monitored over time. For growth tests with glucose as carbon source, cells were washed once in water and inoculated to an OD~660~ of 0.2 in SM with 20 g L^−1^ glucose. OD~660~ was monitored until stationary phase was reached. Specific growth rates were calculated from at least six data points evenly distributed during the exponential growth phase.

Samples were taken and spun down (3 min at 13,000 g) for substrate and extracellular metabolite concentration determination by high-performance liquid chromatography (HPLC) analysis. HPLC analysis was performed with an Agilent 1100 HPLC (Agilent Technologies) equipped with an Aminex HPX-87H ion-exchange column (Bio-Rad, Veenendaal, The Netherlands) kept at 60°C, eluted with sulfuric acid (5 mM, 0.6 mL min^−1^). Detection of glucose, ethanol and glycerol was performed by a refractive-index detector (Agilent G1362A).

RESULTS AND DISCUSSION {#sec3}
======================

Experimental design for CRISPR-***Sp***Cas9-mediated deletion of 21 hexose transporter genes {#sec3-1}
--------------------------------------------------------------------------------------------

To construct a new hexose null *S. cerevisiae* strain, the complete set of 21 transporter genes that were shown to promote growth on hexoses in the CEN.PK strain background (Wieczorke *et al.*[@bib51]) were deleted (Fig. [1A](#fig1){ref-type="fig"}). The starting strain, IMX672, was constructed by integration of a copy of the constitutively expressed *Sp*Cas9-encoding gene in the *CAN1* locus of CEN.PK2-1C, a quadruple auxotrophic strain belonging to the CEN.PK family (*trp1-1 leu2-3,112 his3Δ ura3-52*, Table [1](#tbl1){ref-type="table"}; Mans *et al.*[@bib23]). Integration of a single copy of *Sp*Cas9-encoding gene under the control of a strong promoter in *S. cerevisiae* has been shown to enable high genome editing efficiency, while preventing toxicity caused by excessive *Sp*Cas9 expression levels (Mans *et al.*[@bib23]).

The sequences of *S. cerevisiae* hexose transporter genes are highly homologous. A single, carefully designed sgRNA can therefore be used to simultaneously target multiple homologous *HXT* genes (Marques *et al.*[@bib25]). sgRNA 1 was used to target simultaneously *HXT1* and *HXT3*, although the PAM sequence was different for the two loci (Fig. [1B](#fig1){ref-type="fig"}). The PAM sequence is not present on the delivered sgRNA but is essential to guide *Sp*Cas9 to the correct target (Mojica *et al.*[@bib26]), which enables a single sgRNA to target the same sequence even when it is framed by different PAM sequences. sgRNA 5 was designed to edit *HXT13*, *HXT15* and *HXT16* simultaneously, sgRNA 7 targeted *HXT9*, *HXT11* and *HXT12* and sgRNA 9 targeted *MPH2* and *MPH3*. Conversely sgRNAs 2, 3, 4, 6, 8, 10 and 11 targeted unique loci. In total, 11 sgRNAs were designed to edit the 21 hexose transporter genes. Following the method described by Mans *et al.* ([@bib23]), plasmids carrying two identical or different sgRNAs (called sgRNA plasmids) were constructed and transformed in combinations of two to achieve multiplexing. Three transformation rounds were performed to delete all 21 hexose transporter genes. During transformation, double-stranded DNA fragments of 120 nucleotides (repair DNA) carrying 60 bp homology with sequences upstream and downstream the *Sp*Cas9-mediated editing sites were provided to delete the targeted genes. The only exception was the DNA fragment used to delete *HXT3*, *HXT6* and *HXT7* which was longer and carried *ARS4* to replace the autonomously replicating sequence region located between *HXT6* and *HXT7* (Fig. [1B](#fig1){ref-type="fig"}). After each transformation round, these sgRNA plasmids were removed by cultivation in rich, non-selective medium.

In the first transformation round, nine hexose transporter genes were deleted simultaneously using two CRISPR plasmids, pUDR211 and pUDR295. *HXT1*, *HXT4* and *HXT5* are clustered on chromosome VIII and *HXT3*, *HXT6* and *HXT7* on chromosome IV (Fig. [1A](#fig1){ref-type="fig"}). As mentioned above, sgRNA 1 was designed to edit simultaneously *HXT1* and *HXT3*. By supplying repair DNA fragments with homology up- and downstream of the entire clusters, all six hexose transporter genes could be simultaneously deleted. pUDR295 carried sgRNA 1 together with sgRNA 2 targeting *GAL2*. pUDR211 also contained two sgRNAs, sgRNA 3 targeting *HXT8* and sgRNA 4 targeting *HXT14*. IMX672 was transformed with 1 μg of each plasmid (pUDR211, pUDR295) and 2 μg of each of the five repair DNA fragments. Only two colonies appeared on the transformation plates; however, diagnostic PCR revealed that one of these colonies harbored the expected nine deletions (Supplemental Material [2](#sup1){ref-type="supplementary-material"}). Mans *et al.* ([@bib23]) observed a negative correlation between the number of targeted loci and the number of transformants counted on plates, with as few as 14 ± 2 colonies when simultaneously targeting six loci. The low number of transformants obtained with five independent editing events is therefore in line with these earlier observations. After removal of the sgRNA plasmids, one strain was stocked as IMX1521.

In the second transformation, eight hexose transporter genes were simultaneously targeted: *HXT2*, *HXT9*, *HXT10*, *HXT11*, *HXT12*, *HXT13*, *HXT15* and *HXT16*. pUDR214 carried sgRNA 5 targeting *HXT13*, *HXT15* and *HXT16* and sgRNA 6 targeting *HXT2*. pUDR220 carried sgRNA 7 targeting *HXT9*, *HXT11* and *HXT12* and sgRNA 8 targeting *HXT10*. IMX1521 was transformed with pUDR214, pUDR220 and six repair fragments. In an attempt to increase the number of clones obtained after transformation, the quantity of each plasmid (pUDR214 and pUDR220) was increased from 1 to 2 μg in the second transformation, which resulted in 23 transformants. Out of seven colonies checked by diagnostic PCR, one displayed the expected pattern (Supplemental Material [2](#sup1){ref-type="supplementary-material"}). The sgRNA plasmids were again removed by cultivation on rich medium with maltose as carbon source, and one strain was stocked as IMX1541.

The final transformation round targeted four genes: *MPH2*, *MPH3*, *MAL11* (also known as *AGT1*) and *STL1* with three sgRNAs. pUDR217 carried sgRNA 9 targeting the homologs *MPH2* and *MPH3* and sgRNA 10 targeting *MAL11*. Harbored by pUDR418, sgRNA 11 was designed to target *STL1*. IMX1541 was transformed with pUDR217 and pUDR418 (2 μg each) and three repair DNA fragments, resulting in 433 transformants. Four out of eleven transformants tested by diagnostic PCR displayed the expected four deletions (Supplemental Material [2](#sup1){ref-type="supplementary-material"}). One of the transformants was grown on non-selective medium to recycle the sgRNA plasmids and stocked as IMX1812.

Physiological characterization of the CRISPR-*Hxt*^0^ strain IMX1812 {#sec3-2}
--------------------------------------------------------------------

IMX1812 was grown in shake-flask with chemically defined medium using 2% glucose as sole carbon source. As observed for EBY.VW4000, no growth, glucose consumption or ethanol production could be detected after 4 weeks of culture (Supplemental Material [3](#sup1){ref-type="supplementary-material"}), confirming that IMX1812 was unable to utilize glucose. While the specific growth rate of EBY.VW4000 on maltose was 15% lower than that of the control strain CEN.PK2-1C (t-test, two-tailed, homoscedastic *P* \< 0.05), IMX1812 grew as fast as the control strains (Fig. [2A](#fig2){ref-type="fig"}). Interestingly, deletion of most major hexose transporters (*hxt1 hxt3-8 hxt14*) in IMX1521 did not visibly affect its ability to grow on solid medium with 2% glucose. As IMX1521 still contained *HXT2*, this result was in line with earlier observations that *S. cerevisiae* carrying only *HXT2* grew as rapidly on media with 1% glucose as a control strain equipped with a full set of hexose transporters (Reifenberger, Freidel and Ciriacy [@bib34]). Conversely, IMX1541 did not grow on 2% glucose on solid medium, confirming that *HXT2*, potentially assisted by some or all of the genes removed in the second deletion round (*HXT9*, *HXT10*, *HXT12*, *HXT13*, *HXT15* and *HXT16*) contributed to the fast growth of IMX1521 on high glucose concentrations.

![Physiological characterization of the CRISPR-Hxt^0^ strain IMX1812 and its ancestors. (**A**) Growth in aerobic shake-flasks with chemically defined medium using maltose as sole carbon source. CEN.PK2-1C: control strain without *Sp*Cas9, IMX672: control strain constitutively expressing *Sp*Cas9 from its genomic DNA, IMX1812: CRISPR-Hxt^0^ strain and EBY.VW4000: Hxt^0^ strain from Wieczorke *et al.* ([@bib51]). All strains are quadruple auxotrophs and were supplied with uracil, leucine, histidine and tryptophan. Data represent the average and mean deviation of biological duplicates for each strain and growth condition. The asterisk indicates a *P* value below 0.05 (Student *t*-test) as compared to the control strain CEN.PK2-1C. (**B**) Growth on chemically defined medium with various carbon sources. IMX1521 and IMX1541 were obtained after the first and second transformation round, respectively. The pictures were taken after 2 days of incubation at 30°C.](foy107fig2){#fig2}

As previously described for EBY.VW4000, deletion of 21 hexose transporter genes abolished growth on fructose, galactose and mannose in IMX1812 (Wieczorke *et al.*[@bib51]; Fig. [2B](#fig2){ref-type="fig"}). Growth on galactose was already fully abolished after the first transformation round. During this transformation, *GAL2*, encoding the major galactose transporter (Tschopp *et al.*[@bib44]) was deleted, as well as *HXT14* which encodes a transporter that favors the transport of galactose over other hexoses (Wieczorke *et al.*[@bib51]). While Wieczorke and co-workers showed that galactose uptake was detected when either *HXT9*, *HXT10* or *HXT11* were overexpressed in an *hxt1-17 gal2* deletion strain, the present results demonstrated that their presence in the genome of IMX1512 in a single copy was not sufficient to promote growth on galactose (Fig. [2B](#fig2){ref-type="fig"}). IMX1521 grew as well as the control strain with fructose or mannose as sole carbon source. Most hexose transporters can transport fructose and mannose, albeit with low affinity (Reifenberger, Boles and Ciriacy [@bib33]; Wieczorke *et al.*[@bib51]). The presence of *HXT2*, *HXT9*-*13*, *HXT15* and *HXT16* in IMX1521 was therefore sufficient to sustain near-wildtype growth rates on glucose, fructose and mannose. IMX1541 was unable to grow on 2% glucose, fructose and mannose, indicating that, in agreement with Wieczorke *et al.* ([@bib51]), *MPH2*, *MPH3*, *MAL11* and *STL1* were not sufficient to sustain growth on these carbon sources.

The CRISPR-*Hxt*^0^ strain IMX1812 is devoid of chromosomal alterations {#sec3-3}
-----------------------------------------------------------------------

In the HXT^0^ EBY.VW4000, a sequential deletion campaign that involved repeated use of the LoxP/Cre system has resulted in extensive chromosomal rearrangements (Fig. [3A and B](#fig3){ref-type="fig"}; Solis-Escalante *et al.*[@bib40]). While *Sp*Cas9 editing has not been reported to lead to similar chromosomal rearrangements in haploid *S. cerevisiae* strains, our deletion strategy involved simultaneous editing of highly homologous genes located on different chromosomes, using the same target sequence. Upon editing, the homologous recombination machinery has two types of homologous sequences at its disposal that can be used for repair of double-strand breaks induced by *Sp*Cas9. As an alternative to the repair DNA fragments supplied during transformation, freshly edited genomic DNA with high sequence homology might be used. The possibility of chromosomal rearrangements could therefore not be excluded, more particularly for genes located in subtelomeric regions, which are known to be recombinogenic and a source of genetic variability (Horowitz, Thorburn and Haber [@bib14]; Dujon and Louis [@bib8]). In particular *HXT9*, *HXT11* and *HXT12* are located close to telomeres on chromosomes X, XV and IX respectively, and were deleted in the second transformation round with a single sgRNA (Fig. [1](#fig1){ref-type="fig"}). Similarly, *MPH2* and *MPH3*, which are highly homologous and located near the telomeres of chromosomes IV and X respectively, were deleted simultaneously with a single sgRNA in the third transformation round (Fig. [1](#fig1){ref-type="fig"}).

![Genomic characterization of the CRISPR-Hxt^0^ strain IMX1812, its ancestors and EBY.VW4000. (**A**) Karyotyping using pulse-field electrophoresis. Red arrows indicate size decrease of chromosomes as consequence of CRISPR-based hexose transporter genes deletion (Supplemental Material [4](#sup1){ref-type="supplementary-material"}). Blue boxes indicate polymorphisms in EBY.VW4000 as compared to the control strains CEN.PK113-7D. (**B**) Circos plot comparing the chromosomes of EBY.VW4000 (left side of the circle, indicated in red) and of the control strain CEN.PK113-7D (right side of the circle, indicated in blue). (**C**) Circos plot comparing the chromosomes of IMX1812 (left side of the circle, indicated in red) and of the control strain CEN.PK113-7D (right side of the circle, indicated in blue). (**D**) Chromosome copy number variation of IMX1812 based on Nanopore sequencing data. Blue dots represent the parental strain CEN.PK2-1C and red dots the Hxt^0^ strain IMX1812. (**E**) Cellular DNA content measurement by flow cytometry. CEN.PK113-7D and CEN.PK122 are the haploid and diploid controls, respectively.](foy107fig3){#fig3}

Karyotyping by CHEF electrophoresis of IMX1812 revealed a chromosomal pattern that was near-identical to that of its parental strain IMX672 (Fig. [3A](#fig3){ref-type="fig"}). The small shift towards smaller size of chromosomes VIII and X was readily explained by the deletion of multiple genes on these chromosomes in IMX1812 (*HXT1*, *HXT4* and *HXT5* deletion on chromosome VIII with expected size reduction of 9253 bp; *HXT8*, *HXT9*, *HXT16* and *MPH3* on chromosome X with expected size reduction of 9319 bp; see Supplemental Material [4](#sup1){ref-type="supplementary-material"}). In other cases, deletions were either too small or the chromosomes in which they were introduced too large to detect deletions by CHEF electrophoresis (Supplemental Material [4](#sup1){ref-type="supplementary-material"}). The similarity between IMX1812 and the control strains CEN.PK113-7D, CEN.PK2-1C and IMX672 suggested the absence of chromosomal rearrangements in IMX1812.

Whole genome sequence of the CRISPR-*Hxt***^0^** strain IMX1812 {#sec3-4}
---------------------------------------------------------------

Although Illumina sequencing technology was able to detect chromosomal translocations in the EBY.VW4000 genome (Solis-Escalante *et al.*[@bib40]), the short size of the sequencing reads prevented resolution of the sequence of repeated regions. Especially in subtelomeric regions, this limitation resulted in a fragmented assembly. The advent of third generation sequencing technology, such as nanopore sequencing, has considerably improved the completeness of sequenced genomes, yielding near complete draft chromosome sequences with telomere-to-telomere coverage. The only chromosomal region still resisting accurate sequencing is the region of chromosome XII carrying rDNA (Venema and Tollervey [@bib46]). To check for the occurrence of chromosomal rearrangements, the CRISPR-*Hxt^0^* strain IMX1812 was sequenced with Oxford Nanopore Technology MinION platform.

The MinION assembly of the IMX1812 genome resulted in only 19 contigs, which represents a near 6-fold reduction in the number of contigs as compared to the EBYWV4000 genome assembly that was derived from multiple (mate and paired-end) libraries (Solis-Escalante *et al.*[@bib40]). All nuclear chromosomes, with the exception of chromosome XII, were assembled in single contigs with telomere-to-telomere coverage. Chromosome XII was split in three contigs; the first included sequences ranging from the left telomere to the left end of the ribosomal DNA (rDNA) locus, the second included sequences ranging from the right end of the rDNA locus to the right telomere and the third contig, smaller in size (∼90 kb), representing an embryo of the rDNA locus. The latter contig was also exhibiting a higher coverage than the rest of the assembly, in line with the repetitive nature of rDNA (Venema and Tollervey [@bib46]). Although assembled separately, the three chromosome XII contigs shared homology at their end, enabling their homology-based concatenation into a chromosome XII scaffold. The mitochondrial genome was also reassembled into a single contig. Considering the error rate of this third-generation sequencing method, IMX1812 was also sequenced by Illumina technology and the resulting sequence was used to polish the Oxford Nanopore assembly. In comparison to the previous EBYVW4000 assembly, the present IMX1812 genome captures an additional 700 kb (Table [3](#tbl3){ref-type="table"}; Solis-Escalante *et al.*[@bib40]).

###### 

Quality of genome assembly of the Hxt^0^ strains IMX1812 and EBY.VW4000.

                                  EBY.VW4000[^a^](#tb3fn1){ref-type="table-fn"}   IMX1812
  ------------------------------- ----------------------------------------------- ----------
  Technology                      Illumina paired-end                             Nanopore
                                  and mate-pair                                   
  Scaffolds/contigs (\>500 bp)    104                                             19
  Largest scaffold/contig (Mbp)   1.045                                           1.479
  Average scaffold/contig (Mbp)   0.116                                           0.640
  N50 (Mbp)                       0.423                                           0.804
  Total assembly size (Mbp)       11.5                                            12.2

^a^Solis-Escalante *et al.* ([@bib40]).

Inspection of IMX1812 genome sequence confirmed the complete absence of chromosomal rearrangements (Fig. [3C and D](#fig3){ref-type="fig"}). Ploidy check by flow cytometry was in line with the sequencing data, confirming that the constructed strains remained haploid throughout the successive transformation rounds (Fig. [3E](#fig3){ref-type="fig"}). Further scrutiny of IMX1812 genome sequence confirmed the deletion of the 21 hexose transporter genes. For all genes, *Sp*Cas9-mediated genome editing was repaired precisely as expected based on the sgRNA target and the supplied repair DNA fragments. Combining Illumina and nanopore sequencing revealed the absence of gene loss in IMX1812 as compared to its parent CEN.PK2-1C (Fig. [3D](#fig3){ref-type="fig"}), but identified nine SNPs and a single indel located on six ORFs (*TMN3*, *SPT16*, *MUC1*, *MNN5*, *LAP4* and *ALT1*; Table [4](#tbl4){ref-type="table"}). These ORFs were located at least 26 kb from the deletion sites and shared no homology with any of the 11 sgRNAs, suggesting that they most likely did not result from *Sp*Cas9 activity but rather from random events caused by the three consecutive transformation rounds. *TMN3*, *SPT16*, *MNN5*, *LAP4* and *ALT1* carried a single SNP, leading to an amino acid change. Of these genes only *SPT16*, encoding a subunit of the FACT complex, is essential, and depletion of Spt16 leads to chromosome rearrangements and loss (Schlesinger and Formosa [@bib37]). The fast growth on maltose and absence of chromosomal rearrangements in IMX1812 suggested that Spt16 function was not affected in the Hxt^0^ strain. Impairment of Tmn3, Mnn5 and Lap4 (also known as Ape1) functions are not expected to substantially affect *S. cerevisiae* physiology (Cueva, Garcia-Alvarez and Suarez-Rendueles [@bib7]; Rayner and Munro [@bib32]), in agreement with the absence of phenotypic difference between IMX1812 and its ancestor during growth on maltose (Fig. [2A](#fig2){ref-type="fig"}). Impairment of the activity of the alanine transaminase Alt1 results in growth defects in media supplied with ammonium as sole nitrogen source (Peñalosa-Ruiz *et al.*[@bib29]). Such a phenotype was however not observed for IMX1812 (Fig. [2](#fig2){ref-type="fig"}). Surprisingly, *MUC1*, also known as *FLO11* and involved in flocculation and pseudohyphal growth, was mutated by three SNPs (two of them leading to an amino acid change) and a 269 bp deletion, which most probably led to a loss of function (Table [4](#tbl4){ref-type="table"}). As in many common laboratory *S. cerevisiae* strains, strains from the CEN.PK family are deficient in flocculation and pseudohyphal growth (Liu, Styles and Fink [@bib19]), and mutations in *FLO11* are therefore not likely to affect IMX1812 phenotype. Additionally, Illumina sequencing of the genome of CEN.PK2-1C and of the strains derived from CEN.PK2-1C (IMX672, IMX1541 and IMX1812; Table [1](#tbl1){ref-type="table"}) revealed that, conversely to current records, the *TRP1* mutation in this lineage did not correspond to the *trp1-289* alteration (Botstein *et al.*[@bib5]; Entian and Kötter [@bib9]) but matched the *trp1-1* characterized by a C to T change at position +403, resulting in the introduction of an amber stop codon (Cag-Tag) (<https://wiki.yeastgenome.org>). Accordingly, EBY.VW4000, based on CEN.PK2-1C, also harbored the *trp1-1* mutation.

###### 

List of SNPs identified in IMX1812 genome sequence as compared to its parental strain CEN.PK2-1C.

  Chr.      ORF       Syst. name   Position          Mutation type[^a^](#tb4fn1){ref-type="table-fn"}   Amino acid change
  --------- --------- ------------ ----------------- -------------------------------------------------- --------------------
  **V**     *TMN3*    YER113C      390.575           NSY                                                Asp-61-Tyr (G→T)
  **VII**   *SPT16*   YGL207W      111.686           NSY                                                Ile-165-Val (A→G)
  **IX**    *MUC1*    YIR019C      384.267-384.535   269 bp deletion                                    
            *MUC1*    YIR019C      384.543           NSY                                                Gly-1108-Val (G→T)
            *MUC1*    YIR019C      384.548           SYN                                                Thr-1106-Thr (C→A)
            *MUC1*    YIR019C      384.565           NSY                                                Ser-1101-Ala (T→G)
  **X**     *MNN5*    YJL186W      69.736            NSY                                                Asn-264-Lys (C→A)
  **XI**    *LAP4*    YKL103C      253.049           NSY                                                Lys-320-Glu (A→G)
  **XII**   *ALT1*    YLR089C      298.577           NSY                                                Ile-120-Thr (T→C)
  **XVI**   *FHL1*    YPR104C      742.545           NSY                                                Asn-669-Lys (T→A)

^a^NSY: Non-Synonymous mutation, SYN: Synonymous mutation.

CONCLUSION {#sec4}
==========

The present work provides an Hxt^0^ strain that is genetically near-identical to its hexose transport proficient ancestor. In-depth analysis of IMX1812 revealed the absence of undesired recombination, duplication or excision events during the three transformation rounds performed to delete the 21 hexose transporter genes. Despite the few SNPs caused by these transformations, IMX1812 is genetically and phenotypically closer to its hexose transport proficient ancestor than EBY.VW4000. The extremely high fidelity of genome editing, despite the simultaneous targeting of multiple (subtelomeric) loci with high homology, highlights the power of CRISPR-*Sp*Cas9 editing for extensive strain construction programs.

The present study also provides an 'Hxt^0^ CRISPR toolkit' composed of a set of plasmids, efficient sgRNAs and repair DNA that enables the abolishment of glucose transport in strains from the CEN.PK family. Thanks to the high conservation of hexose transporter genes (Bisson, Fan and Walker [@bib2]), the application of this toolkit is not restricted to the CEN.PK strain family. For instance, based on published genome sequences, the Hxt^0^ CRISPR toolkit can be directly used to turn S288C and its BY4741 derivatives into Hxt^0^ strains. Although, contrary to CEN.PK strains, S288C and its derivatives contain a genomic copy of *HXT17*, the strong homology between *HXT17*, *HXT15* and *HXT16* enables sgRNA 5, which targets *HXT15* and *HXT16*, to also edit *HXT17* during the second transformation round. Not only the plasmids, but also the repair DNA fragments designed for CEN.PK, can be used for these popular laboratory strains. Of course, an additional DNA fragment would have to be designed and supplied to repair the double strand break upon *HXT17* editing.

IMX1812 is available upon request and the sgRNA plasmids have been deposited to Addgene (see Table [2](#tbl2){ref-type="table"} for accession numbers).
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